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ABSTRACT 
 
A poly(L-lactide-co-caprolactone) copolymer, P(LL-co-CL), of composition 75:25 mol % 
was synthesized via the bulk ring-opening copolymerization of L-lactide and ε-caprolactone 
using a novel bis[tin(II) monooctoate] diethylene glycol coordination-insertion initiator, 
OctSn-OCH2CH2OCH2CH2O-SnOct.  The P(LL-co-CL) copolymer obtained was 
characterized by a combination of analytical techniques, namely: nuclear magnetic resonance 
spectroscopy, gel permeation chromatography, dilute-solution viscometry, differential 
scanning calorimetry and thermogravimetric analysis.  For processing into a monofilament 
fiber, the copolymer was melt spun with minimal draw to give a largely amorphous and 
unoriented as-spun fiber.  The fiber’s oriented semi-crystalline morphology, necessary to give 
the required balance of mechanical properties, was then developed via a sequence of 
controlled off-line hot-drawing and annealing steps.  Depending on the final draw ratio, the 
fibers obtained had tensile strengths in the region of 200-400 MPa. 
 
Keywords: L-Lactide, caprolactone, poly(L-lactide-co-caprolactone), ring-opening 
polymerization, tin(II) alkoxide, melt spinning, monofilament fiber, surgical suture 
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1. Introduction 
For many years now, biodegradable polyesters have found use in a wide range of biomedical 
applications such as surgical sutures, bone fixation devices, drug delivery matrices, nerve 
guides and scaffolds for tissue engineering [1-3].  After serving their intended purpose, they 
are gradually broken down by hydrolysis and the degradation products eliminated via the 
body’s normal biological processes.  Synthetic polymers have the advantage over natural 
polymers in that their microstructures can be tailored over a wide range of compositions in 
order to meet the specific requirements of a given application.   
Poly(L-lactide) (PLL), or poly(lactic acid) (PLA) as it is more commonly known, is 
the most widely documented biodegradable polyester [4].  However, the properties of PLL by 
itself as a homopolymer are often found to be unsuitable for certain biomedical applications.  
For example, PLL is too stiff and springy to be used as a monofilament suture due to its high 
glass transition temperature (Tg) of around 60ºC.  Consequently, L-lactide is often 
copolymerized with one or more other cyclic ester monomers in order to produce a 
copolymer with the required balance of properties.  Typical examples are co- and terpolymers 
of L-lactide, glycolide (G) and caprolactone (CL) where the G content increases the rate of 
absorption and the CL content increases flexibility [5-12].   
An important factor in the ring-opening polymerization (ROP) of cyclic esters is the 
choice of initiator.  Tin(II) 2-ethylhexanoate, otherwise known as tin(II) octoate or stannous 
octoate, Sn(Oct)2, has been the most commonly used initiator either by itself or more 
commonly in combination with an alcohol ROH as a co-initiator.  However, it is now widely 
accepted that, when used in combination, the Sn(Oct)2 and ROH react together in situ to 
generate a tin(II) monoalkoxide, OctSnOR, and/or dialkoxide, Sn(OR)2, which are the true 
initiating species [13-16].  Both initiation and propagation occur via coordination-insertion of 
the monomer into the Sn-OR bond of the initiator.  Although effective and convenient to use, 
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a disadvantage of the Sn(Oct)2/ROH initiating system is that the alkoxide species are 
generated in situ in uncertain concentrations which in turn introduces a degree of 
unpredictability into the final polymer molecular weight that is obtained. 
Although P(LL-co-CL) copolymers have been reported in the literature for use in a 
wide range of biomedical applications, relatively little attention has been paid to absorbable 
sutures, possibly because of their slow rate of absorption (typically 6-12 months) in the 
human body.  However, in other applications where slow absorption is required, such as 
long-term drug delivery systems [17], barrier membranes [18], nerve guides [19,20], 
bioadhesives [21] and scaffolds for tissue engineering [22-24], P(LL-co-CL) copolymers 
have been shown to be effective and versatile materials which can be tailored through their 
composition to meet the specific property requirements of a given application.  This paper 
now describes the synthesis, characterization and fiber processing of a P(LL-co-CL) 
copolymer for potential use as an absorbable monofilament surgical suture.           
  Compared with what has been previously reported, there are two aspects to the 
novelty of this work.  Firstly, in the synthesis step, the true alkoxide initiator from the tin(II) 
octoate and diethylene glycol, Sn(Oct)2/DEG, initiating system was prepared separately so 
that it could be isolated and then used in an accurately known concentration rather than 
generated in situ.  Secondly, for fiber processing, the melt spinning, hot-drawing and 
annealing steps were conducted separately in a multi-step process rather than combined in a 
continuous process.  The advantages of doing this were that it allowed more control over the 
development of fiber morphology (molecular orientation, degree of crystallinity) while, at the 
same time, allowing the changes to be monitored after each step until the required balance of 
mechanical properties (strength and flexibility) was obtained.  Thus, the underlying theme of 
this work, bearing in mind the stringent property requirements of a monofilament surgical 
suture, has been to try to control both the chemical and physical microstructure of the 
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copolymer and its fiber at each stage of preparation.  In this way, the process as a whole 
could be relied upon to yield, both predictably and reproducibly, a final product with the 
required properties. 
 
2. Experimental 
2.1 Materials 
L-Lactide was synthesized from L-lactic acid (Grand Chemical Far East Ltd., 88%) and 
purified by repeated recrystallization from ethyl acetate.  After drying to constant weight in a 
vacuum oven at 55oC, pure L-lactide was obtained as a white crystalline solid with a 
chemical purity  99.5% (from DSC purity analysis).  Commercial -caprolactone (Acros, 
99%) was purified by vacuum distillation over calcium hydride.  Tin(II) octoate (Sigma-
Aldrich, 95%) and diethylene glycol (Sigma-Aldrich,  99.5%) were each purified by heating 
with stirring under vacuum in order to remove octanoic acid and moisture impurities 
respectively. 
 
2.2 Instrumental Methods  
Structural analysis was carried out using a Bruker Tensor 27 Fourier-Transform Infrared (FT-
IR) Spectrometer over the wavelength range of 4000-400 cm-1 and a Bruker Avance Nuclear 
Magnetic Resonance (NMR) Spectrometer operating at field frequencies of 400 MHz for 1H-
NMR and 100 MHz for 13C-NMR. 
 Thermal analysis was carried out using a Perkin-Elmer DSC7 Differential Scanning 
Calorimeter (0-200°C, heating rate 10°C/min) and a Perkin-Elmer TGA7 Thermogravimetric 
Analyzer (50-500°C, heating rate 20°C/min). 
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 Copolymer molecular weight determination was performed using a Varian PL-GPC 
50 Plus Gel Permeation Chromatograph (THF solvent, 40°C, flow-rate 1 ml/min) calibrated 
with narrow molecular weight distribution polystyrene standards.  For comparison, intrinsic 
viscosity measurements in chloroform at 30°C were also carried out using a Schott-Gerӓte 
AVS300 Automatic Viscosity Measuring System. 
 Fiber processing was carried out using a Small-Scale Melt Spinning Apparatus 
(Ventures & Consultancy Bradford Ltd., Bradford, UK) which could process as little as 20 g 
of material.  Tensile testing of the fibers was performed using a Lloyds LRX+ Universal 
Mechanical Testing Machine in accordance with the test method described in the European 
Pharmacopoeia 5.0 for synthetic absorbable monofilament sutures [25]. 
 
2.3 Initiator Synthesis 
The novel bis[tin(II) monooctoate] diethylene glycol initiator, OctSn-DEG-SnOct, was 
prepared via the reaction between Sn(Oct)2 and diethylene glycol (DEG), as shown in 
equation (1).  The reaction was carried out at 130ºC for 3 hrs under vacuum.  The lower 
boiling point octanoic acid (2-ethylhexanoic acid, OctH) by-product was driven off as it was 
formed, thereby enabling the reaction to proceed towards completion, as confirmed by FT-IR 
via the disappearance of the broad O-H peak of DEG.  The OctSn-DEG-SnOct initiator was 
obtained as a pale yellow, slightly viscous liquid.   
 
2 Sn(Oct)2  +  HOCH2CH2OCH2CH2OH      OctSn-OCH2CH2OCH2CH2O-SnOct  +  2 OctH  (1)  
tin(II) octoate   DEG                                 OctSn-DEG-SnOct        octanoic acid 
 
However, when the OctSn-DEG-SnOct structure in equation (1) is rearranged so that 
the Sn atom is in the middle flanked by DEG groups, as in DEG-Sn-DEG, a completely 
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different initiator product is obtained.  In this work, this DEG-Sn-DEG initiator was 
synthesized following the original method of Morrison and Haendler [26], as shown in 
equation (2).  After separation from the hydrochloride by-product and purification, it was 
obtained as a white solid compound which, in common with tin(II) alkoxides of the general 
formula Sn(OR)2, was difficult to dissolve and apparently infusible due to its molecular 
aggregation, as represented in equation (3).   
 
   SnCl2   +   2 HOCH2CH2OCH2CH2OH   +   2 (C2H5)3N 
      tin(II) chloride  DEG       triethylamine 
         
  HOCH2CH2OCH2CH2O-Sn-OCH2CH2OCH2CH2OH    +    2 (C2H5)3N.HCl  (2) 
     DEG-Sn-DEG        triethylamine hydrochloride 
 
    n Sn(OR)2           [Sn(OR)2]n    (3) 
             non-aggregated   aggregated 
 
The well-documented solid-state molecular aggregation of Sn(OR)2-type compounds is 
the main drawback to their direct use as initiators in the ROP of cyclic esters [15,26-29].  
Their difficult solubility in cyclic ester monomers and organic solvents leads to complicated 
polymerization kinetics. The final polymer molecular weights are also unpredictable since 
the active site (Sn-OR bond) concentration constantly changes with deaggregation and/or 
solubilization of the initiator.  Consequently, in this present work, primary interest was 
focused on the soluble liquid OctSn-DEG-SnOct initiator for copolymerization purposes. 
 
2.4 Copolymer Synthesis 
Poly(L-lactide-co-caprolactone), P(LL-co-CL), statistical copolymers were synthesized in 
bulk at 130oC for 48 hrs under nitrogen using OctSn-DEG-SnOct initiator concentrations of 
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0.01 and 0.02 mol %.  An initial comonomer mole ratio of LL:CL = 75:25 mol % was used 
since earlier work had shown that, compared with PLL, a P(LL-co-CL) 75:25 copolymer 
would have a sufficiently lower Tg in the region of 20-30ºC due to the flexibilizing effect of 
the CL and yet would still be crystallizable despite the increased structural irregularity [30].  
The copolymers were purified by cutting into small pieces before heating under vacuum at 
55ºC to constant weight.  Percent yields were around 95% which was consistent with the 
expected levels of residual monomer from theoretical equilibrium monomer concentration 
calculations.  The comonomer and copolymer structures are shown in Figure 1. 
 
 
 
 
Fig. 1.  Ring-opening copolymerization of L-lactide and ε-caprolactone. 
 
 
2.5 Fiber Processing 
The P(LL-co-CL) copolymers were melt spun into monofilament fibers using the small-scale 
melt spinning apparatus shown in the schematic diagram in Figure 2.  Prior to melt spinning, 
the copolymer pieces were compressed in the cylinder into pre-formed rods at 140-145oC in 
order to remove any entrapped air which might otherwise have created voids in the extruded 
fiber.  Melt spinning was then carried out from these rods within the temperature range of 
155-165oC depending on the copolymer molecular weight and hence the melt viscosity.  
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Using a 1 mm diameter single circular hole spinneret in combination with fast cooling and 
minimal draw, as-spun fibers were obtained which were largely amorphous and unoriented.  
The purpose of this was so that the required semi-crystalline, oriented morphology could be 
gradually built into the fibers through a series of controlled off-line hot-drawing and 
annealing steps.  Apart from enabling greater morphological control, this multi-step 
procedure also had the advantage of allowing the effects of each individual step to be 
monitored in real time via tensile testing. 
 
 
 
 
Fig. 2.  Small-scale melt spinning apparatus used to produce monofilament fibers. 
 
 
3. Results and Discussion 
3.1 Initiator Characterization  
The FT-IR spectra of Sn(Oct)2, DEG and the OctSn-DEG-SnOct liquid initiator are compared 
in Figure 3.  In the initiator spectrum in Figure 3(c), the disappearance of the broad O-H 
(alcohol) and O-H (carboxylic acid) peaks in the region above 3000 cm-1 confirms the 
complete reaction of the DEG and the efficient removal of the octanoic acid by-product 
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respectively.  Otherwise the various peaks, like those in its 1H-NMR spectrum in Figure 4, 
are consistent with the OctSn-DEG-SnOct chemical structure. 
 
 
 
 
Fig. 3. FT-IR spectra of (a) Sn(Oct)2, (b) DEG and (c) the OctSn-DEG-SnOct liquid initiator. 
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Fig. 4.  400 MHz 1H-NMR spectrum of OctSn-DEG-SnOct in CDCl3 as solvent. 
 
 
In contrast to the well-resolved spectra of the liquid initiator, the FT-IR and 1H-NMR spectra 
of the solid DEG-Sn-DEG initiator, as shown in Figures 5 and 6, show peaks and resonances 
of relatively lower intensity and resolution due to the solid initiator’s molecular aggregation 
and limited solubility.  Despite this, Figures 5 and 6 are still seen to be consistent with the 
DEG-Sn-DEG chemical structure with the broad O-H peak in Figure 5 confirming the 
presence of the OH end-groups of the DEG substituents.      
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Fig. 5.  FT-IR spectrum of the DEG-Sn-DEG solid initiator. 
 
 
 
 
Fig. 6.  400 MHz 1H-NMR spectrum of DEG-Sn-DEG in d6-DMSO as solvent. 
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3.2 Copolymer Characterization  
3.2.1 Composition and Monomer Sequencing 
Copolymer composition and monomer sequencing were characterized by 1H-NMR and 13C-
NMR respectively.  The 1H-NMR spectrum of an OctSn-DEG-SnOct-initiated copolymer is 
shown in Figure 7 as an example.  The copolymer composition was calculated from the peak 
area integrations of the LL methine proton peak (b) at  5.2 and the CL -methylene peak (c) 
at  4.1-4.2.  Since all of the copolymers were obtained in near-quantitative yields ( 95%), 
their compositions are very similar to their initial comonomer feeds, as shown in Table 1. 
 
 
 
Fig. 7.  400 MHz 1H-NMR spectrum of an OctSn-DEG-SnOct-initiated P(LL-co-CL) 
copolymer recorded in CDCl3 as solvent. 
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Monomer sequencing in the P(LL-co-CL) copolymers was characterized from their 
13C-NMR spectra, specifically from the expanded carbonyl carbon (C=O) region from δ = 
169–174 ppm, as shown in Figure 8 as an example.  The heterotriad peaks in between the 
CCC and LLL homotriad peaks are a measure of the degree of randomness of the monomer 
sequencing.  In the triad notations, C represents a caprolactone (CL) unit while L represents 
half a lactide (LL) unit.  For example, the LCL triad sequence corresponds to:  
 
 
 
and its peak in the spectrum is that of the central carbonyl carbon (*). 
The fact that the LLL peak in Figure 8 is so much more prominent than the rest is a 
reflection of not only the higher LL content but also that the monomer sequencing is tapered 
(i.e., partly blocky) rather than random.  This is a direct consequence of the much different 
reactivity ratios (LL >> CL) of the L-lactide and -caprolactone comonomers.  Earlier work 
reported reactivity ratios (r) of rLL = 34.7 and rCL = 0.24 for the LL-CL bulk copolymerization 
at 130ºC using Sn(Oct)2 as the initiator [31].   Thus, L-lactide polymerizes much faster than 
-caprolactone, thereby producing a final copolymer which is initially proportionately rich in 
LL before tapering off towards the end to become proportionately rich in CL.  However, the 
resultant blockiness is offset to a certain extent by transesterification reactions during 
copolymerization which tend to randomize the monomer sequencing.    
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Fig. 8.  Expanded carbonyl region of the 13C-NMR spectrum of an OctSn-DEG-SnOct-
initiated P(LL-co-CL) copolymer recorded in CDCl3 as solvent. 
Note: each peak is that of the carbonyl carbon of the central unit (underlined)  
 
 
Although the large difference in monomer reactivities has the disadvantage of 
yielding a final product which contains a wide range of compositions, it has the advantage of 
producing longer LL sequences than if the sequencing was less blocky and more random.  
This is influential in the wider context of this work since LL is the main crystallizable 
component in the copolymer [32].  Thus, longer LL sequence lengths become important from 
the point of view of enhancing the copolymer’s crystallizability and, in doing so, improving 
its mechanical properties when processed in the form of a monofilament fiber.  
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Table 1.  Comparison of the copolymer compositions, number-average, nM , and weight-
average, wM , molecular weights, polydispersities, PD, and intrinsic viscosities, [η], of the 
P(LL-co-CL) copolymers using OctSn-DEG-SnOct and Sn(Oct)2 as the initiators at different 
concentrations. 
 
 
 
Initiator 
 
 
 
Initiator 
Conc. 
(mol %) 
 
 
Copolymer 
Composition a 
LL:CL (mol %) 
 
 
nM  
 
 
 
wM  
 
PD 
wM / nM  
 
[η] b 
 
(dl/g) 
       
[Sn(Oct)]2DEG 0.01 76 : 24 6.48 x 10
4 1.21 x 105 1.87 1.66 
[Sn(Oct)]2DEG 0.02 75 : 25 4.09 x 10
4 7.48 x 104 1.83 1.24 
       
Sn(Oct)2 0.01 76 : 24 3.86 x 10
4 7.80 x 104 2.02 1.23 
Sn(Oct)2 0.02 77 : 23 1.77 x 10
4 3.45 x 104 1.95 1.21 
       
 
a As determined from the 1H-NMR spectrum 
b As determined in chloroform as solvent at 30°C 
 
3.2.2 Molecular Weight Determination 
Copolymer molecular weights and polydispersities from GPC and intrinsic viscosities from 
dilute-solution viscometry are shown in Table 1.  When compared with the conventional 
Sn(Oct)2 initiator at the same concentrations, the OctSn-DEG-SnOct initiator gave 
significantly higher molecular weights and lower polydispersities.  Previous work has shown 
that for copolymers of this type to be melt spinnable into monfilament fibers that can be hot-
drawn they need to have a number-average molecular weight nM > 30,000 [30].  Both of the 
OctSn-DEG-SnOct-initiated copolymers in Table 1 have nM values above this limit.  
 
3.2.3 Thermal Analysis 
Thermal properties of the P(LL-co-CL) copolymers were investigated by a combination of 
DSC and TGA.  The results are summarized in Table 2 for copolymers prepared using both 
the OctSn-DEG-SnOct and Sn(Oct)2 initiators.  The DSC data was derived from re-heating 
(2nd) scans following intermediate fast cooling so that the copolymer samples were all in an 
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identical quenched amorphous state to enable comparison of their transition temperatures and 
crystallizabilities.  As seen in Table 2, while the various transition and decomposition 
temperatures are quite similar, the significantly higher ∆Hc and ∆Hm values from the OctSn-
DEG-SnOct initiator suggest that it gives rise to a more crystallizable copolymer, possibly 
due to longer average LL sequence lengths and/or less transesterification.  This in turn can be 
interpreted in terms of the effect that the initiator structure and, in particular, the chemical 
and steric environment of the Sn-O bond (active site) has on the initiator’s reactivity.  Greater 
crystallizability is considered to be advantageous for fiber processing since it leads to 
enhanced fiber tensile strength.  
 
Table 2.  DSC and TGA thermal analysis data of the P(LL-co-CL) copolymers synthesized 
using OctSn-DEG-SnOct and Sn(Oct)2 as initiators. 
 
 
 
 
Initiator 
 
 
 
Initiator 
Conc. 
(mol %) 
 
 
DSC 
Tg 
(°C) 
 
DSC 
Tc 
(°C) 
 
 
DSC 
∆Hc 
(J/g) 
 
 
DSC 
Tm 
(°C) 
 
 
DSC 
∆Hm 
(J/g) 
 
TGA 
Td 
(°C) 
        
[Sn(Oct)]2DEG 0.01 29 120  6.8 156 11.0 225 
[Sn(Oct)]2DEG 0.02 28 119 6.7 158 15.1 235 
        
Sn(Oct)2 0.01 29 122 2.4 155 6.5 230 
Sn(Oct)2 0.02 22 104 2.5 146 8.6 224 
        
 
DSC data taken from 2nd heating scan (10°C/min) after fast cooling (200°C/min) 
Tg  =  glass transition temperature (mid-point) 
Tc  =  cold crystallization temperature (peak minimum) 
∆Hc  =  heat of crystallization ( crystallization peak area) 
Tm  =  melting temperature (peak maximum) 
∆Hm  =  heat of melting ( melting peak area) 
Td  =  thermal decomposition temperature (initial weight loss) 
 
With reference to Table 2, it should be mentioned here that, although the Tgs are given as 
single temperatures, they are in fact the estimated mid-points of Tg ranges which can be as 
wide as 10-20°C.  Apart from the nature of the Tg transition itself, the main reason for such 
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broad transitions is the copolymer’s compositional heterogeneity which, in turn, can be traced 
back to the difference in the LL and CL monomer reactivity ratios previously mentioned.  
Therefore, the Tg values in Table 2 should be viewed with this variation in mind.   
 Meanwhile, the TGA data in Table 2 shows thermal decomposition temperatures, Td, 
60-70°C higher than the melting temperatures, Tm.  This gives a reasonably wide temperature 
range within which melt processing can be safely carried out.  It is also worth noting here that 
this highlights another, often unmentioned, role of the CL units in the copolymer.  In addition 
to flexibilizing the copolymer chain, which is their main purpose, they also serve to widen the 
melt processing range relative to PLL by both lowering Tm and increasing Td.  This is 
because CL units are more thermally stable than LL units, as exemplified by the fact that 
PCL has a much higher Td than PLL even though it has a much lower Tm.              
 
3.3 Fiber Processing and Testing 
3.3.1 Melt Spinning 
When the DSC and TGA thermograms are considered together, as shown in Figure 9, they 
are able to define the processing range for melt spinning.  As a general rule, the optimum 
melt spinning temperature is usually taken to be the minimum temperature above Tm (from 
DSC) which gives a suitable melt rheology and which is far enough below the initial weight 
loss temperature (from TGA) to minimize any thermal degradation due to, for example, 
transesterification in the melt state.  Transesterification can be either intra- or intermolecular, 
although intermolecular is statistically the more probable.  Whereas the main effect of 
intermolecular transesterification is merely to widen the molecular weight distribution, 
intramolecular is more damaging since it decreases the average molecular weight.  Thus, 
minimizing both the temperature and the time for melt spinning is an important consideration 
in the fiber processing of polyesters.   
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Fig. 9.  DSC and TGA thermograms on the same temperature scale of the P(LL-co-CL) 
copolymer synthesized using 0.02 mol % OctSn-DEG-SnOct as initiator.  
 
Another important consideration in melt spinning is the effect of moisture.  Polyesters are 
particularly susceptible to hydrolysis when in contact with moisture at high temperature.  
Since hydrolysis leads to random chain scission, the presence of moisture can have a drastic 
effect on molecular weight.  Therefore, it was essential in this work that the copolymer was 
rigorously dried prior to melt spinning and that the processing operation was carried out in a 
humidity-controlled environment.  Fast cooling of the extruded fiber as it emerged from the 
spinneret into the cool room air was also advantageous.    
In this work, all of the copolymers in Tables 1 and 2 could be melt spun into good 
quality monofilament fibers.  However, based on the DSC results in Table 2, the copolymer 
initiated by 0.02 mol % OctSn-DEG-SnOct was chosen for further study due to having the 
highest ∆Hm (crystallizability) value.  From its DSC and TGA thermograms in Figure 9, a 
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melt spinning temperature in the range of 160-165ºC was found to give the best results in 
terms of smooth melt extrusion and a stable filament line.   
  As mentioned previously, the as-spun fiber was purposely obtained with a largely 
amorphous and unoriented morphology so that the required semi-crystalline, oriented 
morphology could be built into it through a series of controlled off-line hot-drawing and fixed 
annealing steps.  Both hot-drawing and annealing are time and temperature-dependent 
processes which have profound effects on matrix morphology and hence fiber properties.  
Hot-drawing, which requires a limited but not excessive amount of chain mobility, needs to 
be carried out at a temperature above the glass transition temperature, Tg, and so in this work 
temperatures of 40, 55 and 70°C were employed and the results compared by tensile testing.  
Similarly, the temperature-time conditions for fixed annealing, which also needed to be 
carried out above Tg, were also varied.  Based on the tensile test results, as described in the 
following section, the highest fiber tensile strength was obtained after a 1st hot-drawing at 
70 °C followed by fixed annealing at 50 °C for 3 hrs and a 2nd hot-drawing at 70 °C.      
 
3.3.2 Tensile Testing 
Tensile testing of the P(LL-co-CL) fiber at the various stages of its processing was carried 
out in accordance with the European Pharmacopoeia 5.0 Test Method for synthetic 
absorbable monofilament sutures [25] using bollard-type sample grips, a 100 N load cell, an 
initial gauge length of 40 mm and a crosshead speed of 80 mm min-1 (initial strain rate = 
200% min-1).  The stress-strain curves of the fiber are shown in Figure 10 and reflect the 
successive changes in morphology brought about by hot-drawing and annealing.  Each tensile 
test was carried out on a minimum of 5 test specimens.  The stress-strain curves in Figure 10 
are those which were considered to be the most representative for each sample.  
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As shown in Figure 10 (left), the most suitable temperature for the 1st hot-drawing, 
based on the fiber’s tensile strength (stress at break), was found to be 70 oC.  Above this 
temperature, the fiber started to become too soft.  Following this 1st hot-drawing, the tensile 
strength increased dramatically, mainly due to increased molecular orientation but also to 
some stress-induced crystallization.  In Figure 10 (right), fixed annealing at 50 °C for 3 hrs 
then allowed molecular relaxation to occur resulting in a further increase in tensile strength.  
However, the main purpose of fixed annealing was to stabilize the hot-drawn morphology 
through molecular relaxation so that the fiber could be drawn again to a higher draw ratio.  
Finally, following the 2nd hot-drawing, the fiber’s tensile strength increased to 344 MPa 
which was found to be comparable with commercial PDS absorbable monofilament sutures 
of similar diameter (size 2-0) under identical test conditions.  This size 2-0 was targeted since 
it is the suture size used in general surgery for bowel repair, a surgical procedure for which 
absorbable monofilaments are routinely used.  The various physical and mechanical 
properties associated with the stress-strain curves in Figure 10 are summarized in Table 3.   
 
 
 
Fig. 10.  Stress-strain curves of the P(LL-co-CL) fiber showing (left) the effects of the 1st hot-
draw temperature and (right) the sequence of effects at the various stages of processing.   
Sequence: As-spun → 1st hot-draw → annealing → 2nd hot-draw                    
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Table 3.  P(LL-co-CL) monofilament fiber physical and tensile properties at the various 
stages of its processing.  
 
 
      
Fiber at the Average Draw Stress Elongation Initial 
various stages diameter ratio d at break e at break modulus f 
of processing a (mm) (λ) (MPa) (%) (MPa) 
      
      
As-spun b 0.80 - 25 1368 85 
1st Hot-draw at 40 °C b 0.52 5.1 134 239 357 
1st Hot-draw at 55 °C b 0.47 5.3 196 111 911 
1st Hot-draw at 70 °C b 0.32 5.7 235 119 633 
      
As-spun c 0.80 - 25 1368 85 
1st Hot-draw at 70 °C c 0.32 5.7 235 119 633 
Anneal at 50 °C for 3 hrs c 0.32 5.7 284 155 618 
2nd Hot-draw at 70 °C c 0.26 8.3 344 70 1173 
      
 
a Sequence: as-spun → 1st hot-draw → anneal → 2nd hot-draw 
b Data from Fig. 10 (left) 
c Data from Fig. 10 (right) 
d Relative to the as-spun fiber 
e Stress at break = tensile strength 
f Measured manually from the initial slope 
 
 
4. Conclusions 
The results described here have shown that P(LL-co-CL) with a ratio of LL:CL = 75:25 mol 
% obtained using the liquid OctSn-DEG-SnOct initiator gave higher molecular weights than 
the conventional Sn(Oct)2 initiator at the same mol % concentration.  The molecular weights 
were also more consistent from batch to batch.  The P(LL-co-CL) copolymers could be melt 
spun into monofilament fibers of uniform diameter with mechanical properties, in particular 
the balance between strength and flexibility, which could be tailored to requirements by 
sequential off-line hot-drawing and annealing steps.  In this way, the fiber’s morphology 
(molecular orientation and crystallinity) could be effectively controlled and changes 
monitored throughout the various stages of processing.  However, it can be appreciated that a 
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multi-step spinning process such as this is only commercially viable for the small-scale batch 
production of high-cost speciality fibers such as those used in suture applications. 
In conclusion, by developing a better understanding of (a) the various factors 
affecting initiator efficiency during synthesis and (b) the changes taking place at the 
molecular level during processing, monofilament fibers with controlled chemical and 
physical microstructure can be obtained.  This control is essential if the stringent property 
requirements demanded of sutures are to be met.  Based on the results described here, it is 
considered that P(LL-co-CL) copolymers synthesized using OctSn-DEG-SnOct as initiator 
have the potential to be developed further as materials for absorbable monofilament sutures.  
However, due to their relatively hydrophobic structure compared with most commercial 
monofilaments, they are more likely to find use in surgical operations where slow suture 
absorption over a period of several months is required.  
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